Sascha A. Tuchman

Statistics

Publications

Citations

2.3K

H-Index

Active since

2004

Affiliations

University of North Carolina at Chapel Hill(Current)

Duke University

Karyopharm Therapeutics (United States)

University of California, Los Angeles

Duke Medical Center

Sascha A. Tuchman is an author at University of North Carolina at Chapel Hill specializing in medicine, multiple myeloma, and multiple myeloma therapy.

ORCID

Publications per year

2004–2024

Publications

Oral Selinexor–Dexamethasone for Triple-Class Refractory Multiple Myeloma

Ajai Chari, Dan T. Vogl, Maria Gavriatopoulou et al. · New England Journal of Medicine · 2019 · 673 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage

Carlos Fernández de Larrea, Robert A. Kyle, Laura Rosiñol et al. · Blood Cancer Journal · 2021 · 174 citations · Full text

Medicine, Hematology, Oncology +15

RETRACTED: Gene Expression Signatures, Clinicopathological Features, and Individualized Therapy in Breast Cancer

Chaitanya R. Acharya, David S. Hsu, Carey K. Anders et al. · JAMA · 2008 · 108 citations

Medicine, Cancer Biology, Oncology +17

Age-Specific Differences in Oncogenic Pathway Dysregulation in Patients With Acute Myeloid Leukemia

Arati V. Rao, Peter J.M. Valk, Klaus H. Metzeler et al. · Journal of Clinical Oncology · 2009 · 94 citations

Medicine, Cancer Biology, Oncology +17

Safety and efficacy of targeting CD138 with a chimeric antigen receptor for the treatment of multiple myeloma

Chuang Sun, Aruna Mahendravada, Brandon Ballard et al. · Oncotarget · 2019 · 94 citations · Full text

Medicine, Hematology, Oncology +16

1–5 of 52